Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -2.030% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CC1=Nc2cc([N+](=O)[O-])ccc2NC(C)(C)C1
b.) C=CCNC(=S)Nc1nc2c(cc1C(=O)OCC)CCCC2
Answer: b. C=CCNC(=S)Nc1nc2c(cc1C(=O)OCC)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCNC(=S)Nc1nc2c(cc1C(=O)OCC)CCCC2
C=CCNC(=S)Nc1nc2c(cc1C(=O)OCC)CCCC2
ethyl 2-(prop-2-enylcarbamothioylamino)-5,6,7,8-tetrahydroquinoline-3-carboxylate